Literature DB >> 25638548

Organ preservation in rectal cancer: have all questions been answered?

Corrie A M Marijnen1.   

Abstract

Improved treatment strategies have eliminated local control as the major problem in rectal cancer. With increasing awareness of long-term toxic effects in survivors of rectal cancer, organ-preservation strategies are becoming more popular. After chemoradiotherapy, both watchful waiting and local excision are used as possible alternatives for radical surgery. Although these seem attractive strategies, many issues about the safety of organ preservation remain. Additionally, radiotherapy strategies are mainly aimed at intermediate and high-risk rectal tumours, and adaptation of this standard practice for a completely new treatment indication has yet to start. This Review will discuss the options and problems of organ preservation, and address the research questions that need to be answered in the coming years, with a specific focus on radiotherapy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25638548     DOI: 10.1016/S1470-2045(14)70398-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  21 in total

Review 1.  [Evidence-based surgery of rectal cancer].

Authors:  M Grade; H Flebbe; B M Ghadimi
Journal:  Chirurg       Date:  2019-05       Impact factor: 0.955

Review 2.  Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives.

Authors:  Matthias F Häfner; Jürgen Debus
Journal:  Visc Med       Date:  2016-06-16

3.  Functional outcomes after TEM in patients with complete clinical response after neoadjuvant chemoradiotherapy.

Authors:  Roberto Ghiselli; Monica Ortenzi; Luca Cardinali; Edlira Skrami; Rosaria Gesuita; Mario Guerrieri
Journal:  Surg Endosc       Date:  2016-11-11       Impact factor: 4.584

4.  18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer.

Authors:  Antonio Avallone; Luigi Aloj; Biagio Pecori; Corradina Caracò; Alfonso De Stefano; Fabiana Tatangelo; Lucrezia Silvestro; Vincenza Granata; Francesco Bianco; Carmela Romano; Francesca Di Gennaro; Alfredo Budillon; Antonella Petrillo; Paolo Muto; Gerardo Botti; Paolo Delrio; Secondo Lastoria
Journal:  J Nucl Med       Date:  2019-03-15       Impact factor: 10.057

5.  Establishment and validation of nomograms for predicting mesorectal lymph node staging and restaging.

Authors:  Zixuan Zhuang; Xueqin Ma; Yang Zhang; Xuyang Yang; Mingtian Wei; Xiangbing Deng; Ziqiang Wang
Journal:  Int J Colorectal Dis       Date:  2022-08-26       Impact factor: 2.796

6.  Endoscopy-Based Deep Convolutional Neural Network Predicts Response to Neoadjuvant Treatment for Locally Advanced Rectal Cancer.

Authors:  Xijie Chen; Junguo Chen; Xiaosheng He; Liang Xu; Wei Liu; Dezheng Lin; Yuxuan Luo; Yue Feng; Lei Lian; Jiancong Hu; Ping Lan
Journal:  Front Physiol       Date:  2022-04-27       Impact factor: 4.755

7.  Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI.

Authors:  Liming Shi; Yang Zhang; Ke Nie; Xiaonan Sun; Tianye Niu; Ning Yue; Tiffany Kwong; Peter Chang; Daniel Chow; Jeon-Hor Chen; Min-Ying Su
Journal:  Magn Reson Imaging       Date:  2019-05-03       Impact factor: 2.546

Review 8.  State of the Art - Rectal Cancer Surgery.

Authors:  Andreas Bogner; Johanna Kirchberg; Jürgen Weitz; Johannes Fritzmann
Journal:  Visc Med       Date:  2019-06-27

9.  Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study.

Authors:  Anouk J M Rombouts; Issam Al-Najami; Natalie L Abbott; Ane Appelt; Gunnar Baatrup; Simon Bach; Aneel Bhangu; Karen-Lise Garm Spindler; Richard Gray; Kelly Handley; Manjinder Kaur; Ellen Kerkhof; Camilla Jensenius Kronborg; Laura Magill; Corrie A M Marijnen; Iris D Nagtegaal; Lars Nyvang; Femke P Peters; Per Pfeiffer; Cornelis Punt; Philip Quirke; David Sebag-Montefiore; Mark Teo; Nick West; Johannes H W de Wilt
Journal:  BMJ Open       Date:  2017-12-28       Impact factor: 2.692

10.  Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer.

Authors:  Sebastian Meltzer; Erta Kalanxhi; Helga Helseth Hektoen; Svein Dueland; Kjersti Flatmark; Kathrine Røe Redalen; Anne Hansen Ree
Journal:  Oncotarget       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.